Goldman Sachs analyst Joe Ritchie initiated coverage of DuPont with a Neutral rating and $53 price target. The company's portfolio shift towards its healthcare and water technologies segment should drive organic growth and margin expansion, the analyst tells investors in a research note. However, Goldman says DuPont revenue and earnings growth estimates rank below its coverage average.
